Biggest changeSee Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information; and • a cash inflow of $461 million related to the formation of the Nutrinova joint venture (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information). • Net Cash Provided by (Used in) Financing Activities Net cash used in financing activities increased $11.7 billion to $1.5 billion for the year ended December 31, 2023 compared to net cash provided by financing activities of $10.3 billion for the same period in 2022, primarily due to: • a decrease in net proceeds of long-term debt, primarily due to the Tender Offer (defined below) of $2.25 billion, payment in full of the 3-year Term Loans (defined below) of $750 million, repayment at maturity of the 1.125% senior unsecured notes during the year ended December 31, 2023, and issuance of the Acquisition Notes (defined below), borrowings under the 3-year and 5-year Term Loans (defined below) during the year ended December 31, 2022 (see Note 11 - Debt in the accompanying consolidated financial statements for further information), which did not recur in the current year; and • an increase in net payments on short-term debt, primarily as a result of payments on our revolving credit facilities and payment in full of the 364-day Term Loans (defined below); 43 Table of Contents partially offset by: • an increase in net proceeds of long-term debt, primarily due to the 2023 Offering (defined below) of $3.0 billion in principal amount during the year ended December 31, 2023 and repayment at maturity of the 4.625% senior unsecured notes during the year ended December 31, 2022; and • a decrease in net payments on short-term debt, primarily due to borrowings on our revolving credit facilities and China Working Capital Term Loan Agreement (defined below) during the year ended December 31, 2023 and borrowing under the senior unsecured revolving credit facility related to the M&M Acquisition in November 2022.
Biggest changeYear Ended December 31, 2024 Compared to Year Ended December 31, 2023 • Net Cash Provided by (Used in) Operating Activities Net cash provided by operating activities decreased $933 million to $966 million for the year ended December 31, 2024 compared to $1.9 billion for the same period in 2023, primarily due to: • unfavorable trade working capital of $654 million, primarily due to inventory reductions compared to those in the prior year driven by balancing production with demand and the timing of settlement of trade payables during the year ended December 31, 2024; • a decrease in Net earnings, excluding the non-cash impacts of impairment losses, primarily due to the goodwill impairment loss of $1.5 billion in the Engineered Materials segment, (see Note 9 - G oodwill and Intangible Assets, Net in the accompanying consolidated financial statements for further information), deferred income taxes of $1.2 billion and the gain of $515 million recognized on the formation of the Nutrinova joint venture during the year ended December 31, 2023, which did not recur in the current year (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information); and • an increase in cash taxes paid of $112 million. • Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities increased $336 million to $470 million for the year ended December 31, 2024 compared to $134 million for the same period in 2023, primarily due to: • a cash inflow of $461 million recognized during the year ended December 31, 2023 related to the formation of the Nutrinova joint venture (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information), which did not recur in the current year. partially offset by: • a decrease of $133 million in capital expenditures during the year ended December 31, 2024. • Net Cash Provided by (Used in) Financing Activities Net cash used in financing activities decreased $143 million to $1.3 billion for the year ended December 31, 2024 compared to $1.5 billion for the same period in 2023, primarily due to: • a decrease in payments on long-term debt, primarily due to our cash tender offer of $2.25 billion completed in August 2023, payment in full of delayed-draw term loans of $870 million and repayment at maturity of the 1.125% senior unsecured notes during the year ended December 31, 2023, that did not recur in the current year, partially offset by repayments at maturity of the 5.900% and 3.500% senior unsecured notes during the year ended December 31, 2024; and • a decrease in net payments on short-term debt, primarily driven by a payment of $500 million on our March 2022 U.S.
See Note 12 - Benefit Obligations in the accompanying consolidated financial statements for further information. Liquidity and Capital Resources Our primary sources of liquidity are cash generated from operations, available cash and cash equivalents, dividends from our portfolio of strategic investments and available borrowings under our senior unsecured revolving credit facility.
See Note 12 - Benefit Obligations in the accompanying consolidated financial statements for further information. Liquidity and Capital Resources Our primary sources of liquidity are cash generated from operations, available cash and cash equivalents, dividends from our portfolio of strategic investments and available borrowings under our senior unsecured revolving credit facilities.
We have directly guaranteed various debt obligations under agreements with third parties related to certain equity affiliates. As of December 31, 2023, we have directly guaranteed $145 million and €31 million of such obligations. We have not entered into any material off-balance sheet arrangements.
We have directly guaranteed various debt obligations under agreements with third parties related to certain equity affiliates. As of December 31, 2024, we have directly guaranteed $145 million and €31 million of such obligations. We have not entered into any material off-balance sheet arrangements.
Discussion of our financial condition and results of operations for the year ended December 31, 2022 compared to the year ended December 31, 2021 and for the year ended December 31, 2021 compared to the year ended December 31, 2020, can be found in Part II - Item 7.
Discussion of our financial condition and results of operations for the year ended December 31, 2023 compared to the year ended December 31, 2022 and for the year ended December 31, 2022 compared to the year ended December 31, 2021, can be found in Part II - Item 7.
On January 4, 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility").
In January 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "CSIT Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "CSIT January 2023 Facility").
Additionally, a Subsidiary Guarantor will be released from its guarantee of the Senior Notes at such time that it ceases to guarantee the Issuer's obligations under the existing U.S. Credit Agreements (subject to the satisfaction of customary document delivery requirements).
Additionally, a Subsidiary Guarantor will be released from its guarantee of the Senior Notes at such time that it 47 Table of Contents ceases to guarantee the Issuer's obligations under the existing U.S. Credit Agreements (subject to the satisfaction of customary document delivery requirements).
Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Reports for the years ended December 31, 2022 and December 31, 2021, respectively.
Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Reports for the years ended December 31, 2023 and December 31, 2022, respectively.
If our cash flow from operations is insufficient to fund our debt service and other obligations, we may be required to use other means available to us such as increasing our borrowings, reducing or delaying capital expenditures, seeking additional capital or seeking to restructure or refinance our indebtedness.
If our cash flow from operations is insufficient to fund our debt service and other obligations, we may be required to use other means available to us such as increasing our borrowings, reducing or delaying capital expenditures, seeking additional capital, further reducing or pausing dividend payments, or seeking to restructure or refinance our indebtedness.
We de-recognized $1.4 billion and $1.1 billion of accounts receivable under this agreement for the years ended December 31, 2023 and 2022, respectively, and collected $1.3 billion and $1.1 billion of accounts receivable sold under this agreement during the same periods.
We de-recognized $1.5 billion and $1.4 billion of accounts receivable under this agreement for the years ended December 31, 2024 and 2023, respectively, and collected $1.5 billion and $1.3 billion of accounts receivable sold under this agreement during the same periods.
Item 1A. Risk Factors of this Annual Report also contains a description of certain risk factors that you should consider which could significantly affect our financial results.
Item 1A. Risk Factors of this Annual Report also contains a description of certain risk factors that you should consider which could significantly affect our business and/or financial results.
There can be no assurance, however, that we will continue to generate cash flows at or above current levels. Total capital expenditures were $568 million for the year ended December 31, 2023.
There can be no assurance, however, that we will continue to generate cash flows at or above current levels. Total capital expenditures were $435 million for the year ended December 31, 2024.
For further information regarding the acquisition and related financing 41 Table of Contents transactions, see Debt and Other Obligations in this Liquidity and Capital Resources and Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information.
For further information regarding the acquisition and related financing transactions, see Debt and Other Obligations in this Liquidity and Capital Resources and Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information.
(the "M&M Acquisition") in order to realize the anticipated benefits of the M&M Acquisition, including synergies and growth opportunities, whether as a result of difficulties arising from the operation of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities; • increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies; 35 Table of Contents • risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all; • risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility; • the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance; • the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; • increased price competition and the introduction of competing products by other companies; • the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with our strategy; • market acceptance of our products and technology; • compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or the Israel-Hamas conflict) or terrorist incidents or as a result of weather, natural disasters, or other crises; • the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to us; • changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions; • changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; • potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters; • potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate; • changes in currency exchange rates and interest rates; and • various other factors, both referenced and not referenced in this Annual Report.
(the "M&M Acquisition"), including synergies and growth opportunities, whether as a result of difficulties arising from the operation of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities; • additional impairments of goodwill or intangible assets; 36 Table of Contents • increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies; • risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all; • risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility; • the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance; • the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; • increased price competition and the introduction of competing products by other companies; • the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with our strategy; • market acceptance of our products and technology; • compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, terrorism or political unrest, public health crises, or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or conflicts in the Middle East) or terrorist incidents or as a result of weather, natural disasters, or other crises; • the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to us; • changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, anti-dumping and countervailing duties, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions; • changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; • potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters; • potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate; • our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemical industry, and the success of our deleveraging efforts, as well as any changes to our credit ratings. • changes in currency exchange rates and interest rates; • tax rates and changes thereto; and • various other factors, both referenced and not referenced in this Annual Report.
In addition, the following factors, among others, could cause our actual results to differ materially from those results, performance or achievements that may be expressed or implied by such forward-looking statements: • changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; • the length and depth of product and industry business cycles particularly in the automotive, electrical, textiles, electronics and construction industries; • volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; • the ability to pass increases in raw material prices, logistics costs and other costs on to customers or otherwise improve margins through price increases; • the possibility that we will not be able to timely or effectively continue to integrate the Mobility & Materials business (the "M&M Business") we acquired from DuPont de Nemours, Inc.
In addition, the following factors, among others, could cause our actual results to differ materially from those results, performance or achievements that may be expressed or implied by such forward-looking statements: • changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; • the length and depth of product and industry business cycles particularly in the automotive, electrical, textiles, electronics and construction industries; • volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, carbon monoxide, wood pulp, hexamethylene diamine, Polyamide 66 ("PA66"), polybutylene terephthalate, ethanol, natural gas and fuel oil, and the prices for electricity and other energy sources; • the ability to pass increases in raw materials prices, logistics costs and other costs on to customers or otherwise improve margins through price increases; • the possibility that we will not be able to realize the anticipated benefits of the Mobility & Materials business (the "M&M Business") we acquired from DuPont de Nemours, Inc.
Unsold U.S. accounts receivable of $109 million were pledged by the SPE as collateral to the Purchasers as of December 31, 2023. • Factoring and Discounting Agreements We have factoring agreements in Europe and Singapore with financial institutions.
Unsold U.S. accounts receivable of $139 million were pledged by the SPE as collateral to the Purchasers as of December 31, 2024. • Factoring and Discounting Agreements We have factoring agreements in Europe, Japan, Singapore and China with financial institutions.
See Note 11 - Debt in the accompanying consolidated financial statements for further information. The Issuer and Subsidiary Guarantors are 100% owned subsidiaries of the Parent Guarantor. The Subsidiary Guarantors are listed in Exhibit 22.1 to this Annual Report.
("Issuer") and are guaranteed by Celanese Corporation ("Parent Guarantor") and the Subsidiary Guarantors (collectively the "Obligor Group"). See Note 11 - Debt in the accompanying consolidated financial statements for further information. The Issuer and Subsidiary Guarantors are 100% owned subsidiaries of the Parent Guarantor. The Subsidiary Guarantors are listed in Exhibit 22.1 to this Annual Report.
We de-recognized $423 million and $320 million of accounts receivable under these factoring agreements for the years ended December 31, 2023 and 2022, respectively, and collected $407 million and $325 million of accounts receivable sold under these factoring agreements during the same periods.
We de-recognized $700 million and $423 million of accounts receivable under these factoring agreements for the years ended December 31, 2024 and 2023, respectively, and collected $640 million and $407 million of accounts receivable sold under these factoring agreements during the same periods.
We are committed to rapid deleveraging and to maintaining our investment grade debt rating. While our contractual obligations, commitments and debt service requirements over the next several years are significant, we continue to believe we will have available resources to meet our liquidity requirements, including debt service, for the next twelve months.
While our contractual obligations, commitments and debt service requirements over the next several years are significant, we continue to believe we will have available resources to meet our liquidity requirements, including debt service, for the next twelve months.
If the actual future results of our operations and cash generation activities differ materially from these expectations, we may be required to seek an amendment to or waiver of any impacted covenants, which may increase our borrowing costs under the existing Global Credit Agreements. 42 Table of Contents Cash Flows Cash and cash equivalents increased $297 million to $1.8 billion as of December 31, 2023 compared to December 31, 2022.
If the actual future results of our operations and cash generation activities differ materially from these expectations, we may be required to seek an amendment to or waiver of any impacted covenants, which may increase our borrowing costs under the existing Global Credit Agreements. 43 Table of Contents Cash Flows Cash and cash equivalents decreased $843 million to $962 million as of December 31, 2024 compared to December 31, 2023.
See Note 14 - Shareholders' Equity in the accompanying consolidated financial statements for further information. 47 Table of Contents Contractual Obligations, Guarantees and Commitments We calculated $3.3 billion of all future interest payments on debt and other obligations using the rate in effect on December 31, 2023 and $495 million of all future pension and other postretirement funding obligations.
See Note 14 - Shareholders' Equity in the accompanying consolidated financial statements for further information. Contractual Obligations, Guarantees and Commitments We calculated $2.5 billion of all future interest payments on debt and other obligations using the rate in effect on December 31, 2024 and $493 million of all future pension and other postretirement funding obligations.
The higher effective income tax benefit rate for the year ended December 31, 2023 compared to the same period in 2022 was primarily due to the relocation of certain intangible assets to better align with the acquired M&M foreign operations, the realignment of our European headquarters and principal operations to Switzerland to achieve operational efficiencies, the release of valuation allowances on U.S. foreign tax credit carryforwards, and the excess of the U.S.
The change in the effective income tax rate for the year ended December 31, 2024 compared to the same period in 2023 was primarily due to: • prior year impacts that did not recur in the current year, including the relocation of certain intangible assets to better align with the acquired M&M foreign operations, the realignment of our European headquarters and principal operations to Switzerland to achieve operational efficiencies, the release of valuation allowances on U.S. foreign tax credit carryforwards, and the excess of the U.S.
This repurchase program does not have an expiration date. During the year ended December 31, 2023, we did not repurchase any shares of our Common Stock. As of December 31, 2023, we had $1.1 billion remaining under authorizations by our Board of Directors.
This repurchase program does not have an expiration date. During the year ended December 31, 2024, we did not repurchase any shares of our Common Stock. As of December 31, 2024, we had $1.1 billion remaining under authorizations by our Board of Directors. As discussed above, as part of our deleveraging efforts, we have paused our share repurchase program.
We continue to see the incremental capacity from investments made in recent years strengthen the growth and reliability of our manufacturing network reliability to best serve our customers. We did not repurchase any Common Stock during the year ended December 31, 2023.
We continue to see the investments made in recent years strengthen the growth and reliability, while lowering the carbon footprint, of our manufacturing network to best serve our customers. We did not repurchase any Common Stock during the year ended December 31, 2024.
See Note 12 - Benefit Obligations in the accompanying consolidated financial statements for further information. 38 Table of Contents Our effective income tax benefit rate for the year ended December 31, 2023 was 67% compared to 34% for the year ended 2022.
See Note 12 - Benefit Obligations in the accompanying consolidated financial statements for further information. Our effective income tax rate for the year ended December 31, 2024 was (51)% compared to (67)% for the year ended 2023.
On December 15, 2023, we entered into a Master Discounting Agreement (the "Master Discounting Agreement") with a financial institution in China to discount, on a non-recourse basis, banker's acceptance drafts ("BADs"), classified as accounts receivable. We received $45 million from the accounts receivable transferred under the Master Discounting Agreement as of December 31, 2023.
We have master discounting agreements (the "Master Discounting Agreements") with financial institutions in China to discount, on a non-recourse basis, banker's acceptance drafts ("BADs"), classified as accounts receivable. We received $100 million and $45 million from the accounts receivable transferred under the Master Discounting Agreements as of December 31, 2024 and 2023.
As of December 31, 2023, $1.5 billion of the $1.8 billion of cash and cash equivalents was held by our foreign subsidiaries. Under the Tax Cuts and Jobs Act, we have incurred a prior year charge associated with the deemed repatriation of previously unremitted foreign earnings, including foreign held cash.
As of December 31, 2024, $627 million of the $962 million of cash and cash equivalents was held by our foreign subsidiaries. Under the Tax Cuts and Jobs Act, we have incurred a prior year charge associated with the deemed repatriation of foreign earnings.
On August 25, 2023, Celanese U.S. completed a cash tender offer for $2.25 billion in aggregate principal amount (the "Tender Offer") as follows: Maturity Date Aggregate Principal Amount Tendered Purchase price per $1,000 principal amount Total Tender Offer Consideration Accrued and Unpaid Interest (In $ millions) (In $ millions) June 30, 2024 1,473 $ 999.92 1,473 12 March 15, 2025 750 $ 1,002.85 752 20 April 30, 2024 27 $ 983.95 27 — The net proceeds from the 2023 Offering were used (i) to fund the Tender Offer and (ii) for the repayment of other outstanding indebtedness, including the payment in full of the 364-day Term Loans and the 3-year Term Loans. 45 Table of Contents • Accounts Receivable Securitization Facility On June 1, 2023, we entered into an amendment to the amended and restated receivables purchase agreement under our U.S. accounts receivable purchasing facility among certain of our subsidiaries, our wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers").
In August 2023, Celanese U.S. completed a public offering of senior unsecured notes registered under the Securities Act as follows (collectively, the "2023 Offering"): Maturity Date Aggregate Principal Amount Issued Discount to Par Interest Rate (In $ millions) November 15, 2028 1,000 99.986% 6.350% November 15, 2030 999 99.950% 6.550% November 15, 2033 1,000 99.992% 6.700% 46 Table of Contents Also in August 2023, Celanese U.S. completed a cash tender offer for $2.25 billion in aggregate principal amount (the "Tender Offer") as follows: Maturity Date Aggregate Principal Amount Tendered Purchase price per $1,000 principal amount Total Tender Offer Consideration Accrued and Unpaid Interest (In $ millions) (In $ millions) July 5, 2024 1,473 $ 999.92 1,473 12 March 15, 2025 750 $ 1,002.85 752 20 May 8, 2024 27 $ 983.95 27 — The net proceeds from the 2023 Offering were used (i) to fund the Tender Offer and (ii) for the repayment of other outstanding indebtedness. • Accounts Receivable Purchasing Facility In June 2023, we entered into an amendment to the amended and restated receivables purchase agreement under our U.S. accounts receivable purchasing facility among certain of our subsidiaries, our wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers").
Non-operating pension and other postretirement employee expense increased for the year ended December 31, 2023 compared to the same period in 2022 primarily due to: • higher interest costs of $66 million and lower expected return on plan assets of $34 million, partially offset by a decrease in recognized actuarial loss of $15 million primarily as a result of a decrease in the weighted average discount rate used to determine benefit obligations from 4.9% to 4.5%.
Non-operating pension and other postretirement employee expense decreased for the year ended December 31, 2024 compared to the same period in 2023 primarily due to: • a decrease in the actuarial loss of $29 million as a result of an increase in the weighted average discount rate used to determine benefit obligations from 4.5% to 4.8%, partially offset by lower than expected actual asset returns.
We expect the China Credit Agreements will facilitate our efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of our U.S. debt to China at a lower average interest rate. 44 Table of Contents • Senior Notes We have outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933 ("Securities Act"), as amended, as follows (collectively, the "Senior Notes"): Senior Notes Issue Date Principal Interest Rate Interest Pay Dates Maturity Date (In millions) (In percentages) 3.500% Notes May 2019 $500 3.500 May 8 November 8 May 8, 2024 5.900% Notes July 2022 $2,000 5.900 January 5 July 5 July 5, 2024 1.250% Notes December 2017 €300 1.250 February 11 February 11, 2025 6.050% Notes July 2022 $1,750 6.050 March 15 September 15 March 15, 2025 4.777% Notes July 2022 €1,000 4.777 July 19 July 19, 2026 1.400% Notes August 2021 $400 1.400 February 5 August 5 August 5, 2026 2.125% Notes November 2018 €500 2.125 March 1 March 1, 2027 6.165% Notes July 2022 $2,000 6.165 January 15 July 15 July 15, 2027 0.625% Notes September 2021 €500 0.625 September 10 September 10, 2028 6.350% Notes August 2023 $1,000 6.350 May 15 November 15 November 15, 2028 5.337% Notes July 2022 €500 5.337 January 19 January 19, 2029 6.330% Notes July 2022 $750 6.330 January 15 July 15 July 15, 2029 6.550% Notes August 2023 $999 6.550 May 15 November 15 November 15, 2030 6.379% Notes July 2022 $1,000 6.379 January 15 July 15 July 15, 2032 6.700% Notes August 2023 $1,000 6.700 May 15 November 15 November 15, 2033 The Senior Notes were issued by Celanese U.S. and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors.
This borrowing and cash on hand were used primarily to repay in full our senior unsecured notes due 2025, with an interest rate of 1.250%, due on February 11, 2025, and for general corporate purposes. • Senior Notes We have outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933 ("Securities Act"), as amended, as follows (collectively, the "Senior Notes"): Senior Notes Issue Date Principal Interest Rate Interest Pay Dates Maturity Date (In millions) (In percentages) 1.250% Notes December 2017 €300 1.250 (1) February 11 February 11, 2025 6.050% Notes July 2022 $1,000 6.050 March 15 September 15 March 15, 2025 4.777% Notes July 2022 €1,000 4.777 July 19 July 19, 2026 1.400% Notes August 2021 $400 1.400 February 5 August 5 August 5, 2026 2.125% Notes November 2018 €500 2.125 March 1 March 1, 2027 6.165% Notes July 2022 $2,000 6.165 January 15 July 15 July 15, 2027 0.625% Notes September 2021 €500 0.625 September 10 September 10, 2028 6.350% Notes August 2023 $1,000 6.350 (2) May 15 November 15 November 15, 2028 5.337% Notes July 2022 €500 5.337 January 19 January 19, 2029 6.330% Notes July 2022 $750 6.330 January 15 July 15 July 15, 2029 6.550% Notes August 2023 $999 6.550 (2) May 15 November 15 November 15, 2030 6.379% Notes July 2022 $1,000 6.379 January 15 July 15 July 15, 2032 6.700% Notes August 2023 $1,000 6.700 (2) May 15 November 15 November 15, 2033 ______________________________ (1) The 1.250% Notes were repaid in full on February 11, 2025.
On October 31, 2023, we announced the planned closure of our Polyamide 66 ("PA66") and High-Performance Nylon ("HPN") polymerization units at our facility in Uentrop, Germany to optimize production costs across our global network. These operations are included in the Engineered Materials segment and we expect to complete the closure in 2024.
See Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements. In October 2023, we announced the intended closure of our PA66 and High-Performance Nylon ("HPN") polymerization units at our facility in Uentrop, Germany to optimize production costs across our global network. These operations are included in the Engineered Materials segment.
We believe that cash flows from our operations, together with synergy opportunities from the M&M Acquisition and cost reduction initiatives, will support our deleveraging efforts over the next few years.
We believe that cash flows from our operations, together with synergy opportunities from the M&M Acquisition and cost reduction initiatives, will support our deleveraging efforts over the next few years. However, we expect the weakened demand environment, as discussed below, to continue to adversely impact our cash generation in the near-term.
Non-operating pension and other postretirement employee expense increased $86 million for the year ended December 31, 2023 compared to the same period in 2022 primarily due to higher interest costs of $66 million and lower expected return on plan assets of $34 million, partially offset by a decrease in recognized actuarial loss of $15 million primarily as a result of a decrease in the weighted average discount rate used to determine benefit obligations from 4.9% to 4.5%.
Non-operating pension and other postretirement employee expense decreased $49 million for the year ended December 31, 2024 compared to the same period in 2023 primarily due to a decrease in recognized actuarial loss of $29 million as a result of an increase in the weighted average discount rate used to determine benefit obligations from 4.5% to 4.8%, 39 Table of Contents partially offset by lower than expected actual asset returns.
Year Ended December 31, 2023 (In $ millions) Net sales to third parties 1,826 Net sales to non-guarantor subsidiaries 1,048 Total net sales 2,874 Gross profit 561 Earnings (loss) from continuing operations 1,464 Net earnings (loss) 1,456 Net earnings (loss) attributable to the Obligor Group 1,456 As of December 31, 2023 2022 (In $ millions) Receivables from non-guarantor subsidiaries 787 754 Other current assets 2,245 1,588 Total current assets 3,032 2,342 Goodwill 536 567 Other noncurrent assets 3,289 2,718 Total noncurrent assets 3,825 3,285 Current liabilities due to non-guarantor subsidiaries 2,993 2,100 Current liabilities due to affiliates 6 2 Other current liabilities 1,940 2,201 Total current liabilities 4,939 4,303 Noncurrent liabilities due to non-guarantor subsidiaries 3,365 3,400 Other noncurrent liabilities 13,007 13,842 Total noncurrent liabilities 16,372 17,242 Share Capital On February 7, 2024, we declared a quarterly cash dividend of $0.70 per share on our Common Stock amounting to approximately $76 million.
Year Ended December 31, 2024 (In $ millions) Net sales to third parties 1,819 Net sales to non-guarantor subsidiaries 1,140 Total net sales 2,959 Gross profit 558 Earnings (loss) from continuing operations (367) Net earnings (loss) (374) Net earnings (loss) attributable to the Obligor Group (374) As of December 31, 2024 2023 (In $ millions) Receivables from non-guarantor subsidiaries 1,138 787 Other current assets 2,372 2,245 Total current assets 3,510 3,032 Goodwill 536 536 Other noncurrent assets 6,386 3,289 Total noncurrent assets 6,922 3,825 Current liabilities due to non-guarantor subsidiaries 5,258 2,993 Current liabilities due to affiliates 5 6 Other current liabilities 2,212 1,940 Total current liabilities 7,475 4,939 Noncurrent liabilities due to non-guarantor subsidiaries 3,371 3,365 Other noncurrent liabilities 11,241 13,007 Total noncurrent liabilities 14,612 16,372 48 Table of Contents Share Capital On February 12, 2025, we declared a quarterly cash dividend of $0.03 per share on our Common Stock amounting to approximately $3 million.
We accounted for our interest in the joint venture as an equity method investment, and our portion of the results will continue to be included in the Engineered Materials segment. For further information regarding the food ingredients joint venture, see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements.
We accounted for our interest in the joint venture as an equity method investment, and our portion of the results will continue to be included in the Engineered Materials segment.
We neither intend nor assume any obligation to update these forward-looking statements, which speak only as of their dates. 36 Table of Contents Results of Operations Financial Highlights Year Ended December 31, 2023 2022 Change (In $ millions, except percentages) Statement of Operations Data Net sales 10,940 9,673 1,267 Gross profit 2,603 2,380 223 Selling, general and administrative ("SG&A") expenses (1,075) (824) (251) Other (charges) gains, net (68) (8) (60) Gain (loss) on disposition of businesses and assets, net 505 5 500 Operating profit (loss) 1,687 1,378 309 Equity in net earnings (loss) of affiliates 102 220 (118) Non-operating pension and other postretirement employee benefit (expense) income (69) 17 (86) Interest expense (720) (405) (315) Interest income 39 69 (30) Dividend income - equity investments 126 133 (7) Earnings (loss) from continuing operations before tax 1,183 1,421 (238) Earnings (loss) from continuing operations 1,973 1,910 63 Earnings (loss) from discontinued operations (9) (8) (1) Net earnings (loss) 1,964 1,902 62 Net earnings (loss) attributable to Celanese Corporation 1,960 1,894 66 Other Data Depreciation and amortization 706 462 244 SG&A expenses as a percentage of Net sales 9.8 % 8.5 % Operating margin (1) 15.4 % 14.2 % Other (charges) gains, net Restructuring (52) (6) (46) Asset impairments (15) (14) (1) Plant/office closures (1) 12 (13) Total Other (charges) gains, net (68) (8) (60) _____________________________ (1) Defined as Operating profit (loss) divided by Net sales.
We neither intend nor assume any obligation to update these forward-looking statements, which speak only as of the dates hereof. 37 Table of Contents Results of Operations Financial Highlights Year Ended December 31, 2024 2023 Change (In $ millions, except percentages) Statement of Operations Data Net sales 10,280 10,940 (660) Gross profit 2,356 2,603 (247) Selling, general and administrative ("SG&A") expenses (1,030) (1,075) 45 Other (charges) gains, net (1,744) (68) (1,676) Gain (loss) on disposition of businesses and assets, net (14) 505 (519) Operating profit (loss) (697) 1,687 (2,384) Equity in net earnings (loss) of affiliates 196 102 94 Non-operating pension and other postretirement employee benefit (expense) income (20) (69) 49 Interest expense (676) (720) 44 Interest income 33 39 (6) Dividend income - equity investments 128 126 2 Earnings (loss) from continuing operations before tax (996) 1,183 (2,179) Earnings (loss) from continuing operations (1,506) 1,973 (3,479) Earnings (loss) from discontinued operations (8) (9) 1 Net earnings (loss) (1,514) 1,964 (3,478) Net earnings (loss) attributable to Celanese Corporation (1,522) 1,960 (3,482) Other Data Depreciation and amortization 801 706 95 SG&A expenses as a percentage of Net sales 10.0 % 9.8 % Operating margin (1) (6.8) % 15.4 % Other (charges) gains, net Restructuring (107) (52) (55) Asset impairments (1,639) (15) (1,624) Plant/office closures 2 (1) 3 Total Other (charges) gains, net (1,744) (68) (1,676) _____________________________ (1) Defined as Operating profit (loss) divided by Net sales.
The cash dividend will be paid on March 5, 2024 to holders of record as of February 20, 2024. Our Board of Directors has authorized the aggregate repurchase of $6.9 billion of our Common Stock since February 2008. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased.
We will continue to evaluate our dividend policy, taking into account our ability to return to a balanced capital allocation policy. Our Board of Directors has authorized the aggregate repurchase of $6.9 billion of our Common Stock since February 2008. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased.
Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million (the "364-day Term Loans") and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion (the "5-year Term Loans").
Debt and Other Obligations • Senior Credit Facilities In March 2022, we entered into a term loan credit agreement (as amended to date, the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion (the "5-year Term Loans").
Guarantor Financial Information We have outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933, as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. ("Issuer") and are guaranteed by Celanese Corporation ("Parent Guarantor") and the Subsidiary Guarantors (collectively the "Obligor Group").
See Note 11 - Debt in the accompanying consolidated financial statements for further information. Guarantor Financial Information We have outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933, as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S.
Each of the Subsidiary Guarantors and our non-guarantor subsidiaries is a distinct legal entity and, under certain circumstances, applicable country or state laws, regulatory limitations and terms of other debt instruments may limit our subsidiaries' ability to distribute cash to the Issuer and the Parent Guarantor. 46 Table of Contents For cash management purposes, we transfer cash among the Parent Guarantor, Issuer, Subsidiary Guarantors and non-guarantors through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries.
Credit Agreements, is the cash that our subsidiaries generate from their operations. Each of the Subsidiary Guarantors and our non-guarantor subsidiaries is a distinct legal entity and, under certain circumstances, applicable country or state laws, regulatory limitations and terms of other debt instruments may limit our subsidiaries' ability to distribute cash to the Issuer and the Parent Guarantor.
GAAP gain over the tax gain from the formation of the Nutrinova joint venture. See Note 15 - Income Taxes in the accompanying consolidated financial statements for further information.
See Note 15 - Income Taxes in the accompanying consolidated financial statements for further information.
As of December 31, 2023 2022 (In $ millions) Balance Sheet Data Cash and cash equivalents 1,805 1,508 Short-term borrowings and current installments of long-term debt - third party and affiliates 1,383 1,306 Long-term debt, net of unamortized deferred financing costs 12,301 13,373 Total debt 13,684 14,679 37 Table of Contents Factors Affecting Business Segment Net Sales The percentage increase (decrease) in Net sales attributable to each of the factors indicated for each of our business segments is as follows: Year Ended December 31, 2023 Compared to Year Ended December 31, 2022 Volume Price Currency Total (In percentages) Engineered Materials 54 (1) — 53 Acetyl Chain 2 (17) — (15) Total Company 23 (10) — 13 Consolidated Results Year Ended December 31, 2023 Compared to Year Ended December 31, 2022 Net sales increased $1.3 billion, or 13%, for the year ended December 31, 2023 compared to the same period in 2022 primarily due to: • higher volume, primarily in our Engineered Materials segment related to the M&M Acquisition and the KEPCO restructuring (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information) and also in our Acetyl Chain segment due to increased demand for most of our products in Asia; partially offset by: • lower pricing, primarily in our Acetyl Chain segment as market and pricing conditions reverted from increased levels in the prior year and also in our Engineered Materials segment due to decreased energy surcharges, market considerations, and an unfavorable product mix; and • lower volume in our Acetyl Chain segment due to decreased demand for vinyl acetate monomer ("VAM"), acid and emulsion polymers in the Western Hemisphere.
As of December 31, 2024 2023 (In $ millions) Balance Sheet Data Cash and cash equivalents 962 1,805 Short-term borrowings and current installments of long-term debt - third party and affiliates 1,501 1,383 Long-term debt, net of unamortized deferred financing costs 11,078 12,301 Total debt 12,579 13,684 38 Table of Contents Factors Affecting Business Segment Net Sales The percentage increase (decrease) in Net sales attributable to each of the factors indicated for each of our business segments is as follows: Year Ended December 31, 2024 Compared to Year Ended December 31, 2023 Volume Price Currency Total (In percentages) Engineered Materials (5) (3) (1) (9) Acetyl Chain 4 (6) — (2) Total Company (1) (4) (1) (6) Consolidated Results Year Ended December 31, 2024 Compared to Year Ended December 31, 2023 Net sales decreased $660 million, or 6%, for the year ended December 31, 2024 compared to the same period in 2023 primarily due to: • lower pricing, driven by our Acetyl Chain segment due to an environment with greater supply than demand, as well as our Engineered Materials segment due to competitive market dynamics, product mix, and decreased energy surcharges; • lower volume in our Engineered Materials segment primarily due to the formation of the Nutrinova joint venture (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information) and reduced demand for elastomers due to weaker automotive demand, partially offset by higher volume, principally for POM in Europe and Asia; and • an unfavorable currency impact, primarily resulting from a weaker Chinese Yuan ("CNY") and Japanese Yen ("JPY") relative to the U.S. dollar; partially offset by: • higher volume in our Acetyl Chain segment for most of our products, primarily methanol, downstream derivative products, acid, and VAM.
As of December 31, 2023, we have $1.75 billion available for borrowing under our senior U.S. unsecured revolving credit facility and $34 million available for borrowing under our separate China Revolving Credit Facility (defined below), if required, in meeting our working capital needs and other contractual obligations.
As of December 31, 2024, we have $1.75 billion available for borrowing under our senior U.S. unsecured revolving credit facility, $171 million available for borrowing under our separate China Revolving Credit Facilities (defined below) and up to $1.0 billion under the November 2024 U.S.
In addition, we held cash and cash equivalents of $1.8 billion as of December 31, 2023. We are actively managing our business to maintain cash flow, and we believe that liquidity from the above-referenced sources will be sufficient to meet our operational and capital investment needs and financial obligations for the foreseeable future.
We are actively managing our business to maintain cash flow, and we believe that liquidity from the above-referenced sources will be sufficient to meet our operational and capital investment needs and financial obligations for the foreseeable future. On February 29, 2024, we announced the intended closure of our facility in Mechelen, Belgium to optimize production costs across our global network.
Acetyl Chain Year Ended December 31, % 2023 2022 Change Change (In $ millions, except percentages) Net sales 4,884 5,743 (859) (15.0) % Net Sales Variance Volume 2 % Price (17) % Currency — % Operating profit (loss) 1,109 1,447 (338) (23.4) % Operating margin 22.7 % 25.2 % Dividend income - equity investments 124 132 (8) (6.1) % Depreciation and amortization 217 213 4 1.9 % Year Ended December 31, 2023 Compared to Year Ended December 31, 2022 Net sales decreased for the year ended December 31, 2023 compared to the same period in 2022 primarily due to: • lower pricing for most of our products, primarily VAM, acid and emulsion polymers, as market and pricing conditions reverted from increased levels in the prior year particularly in Asia and Europe; and • lower volume due to decreased demand for VAM, acid and emulsion polymers in the Western Hemisphere; partially offset by: • higher pricing for acetate tow; and • higher volume due to increased demand for most of our products, primarily in Asia.
Acetyl Chain Year Ended December 31, % 2024 2023 Change Change (In $ millions, except percentages) Net sales 4,763 4,884 (121) (2.5) % Net Sales Variance Volume 4 % Price (6) % Currency — % Operating profit (loss) 951 1,109 (158) (14.2) % Operating margin 20.0 % 22.7 % Dividend income - equity investments 127 124 3 2.4 % Depreciation and amortization 244 217 27 12.4 % Year Ended December 31, 2024 Compared to Year Ended December 31, 2023 Net sales decreased for the year ended December 31, 2024 compared to the same period in 2023 primarily due to: • lower pricing for most of our products globally, due to an environment with greater supply than demand during the year ended December 31, 2024; partially offset by: • higher volume for most of our products, primarily methanol, downstream derivative products, acid, and VAM.
Obligations bear interest at certain fixed and floating rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.
Obligations bear interest at certain fixed and floating rates. On April 7, 2024, the CSIT January 2023 Facility was reduced to CNY750 million and on December 19, 2024, the CSIT January 2023 Facility was reduced to CNY550 million. The CSIT Revolving Credit Agreement is guaranteed by Celanese U.S.
Operating profit increased $309 million, or 22%, for the year ended December 31, 2023 compared to the same period in 2022 primarily due to: • higher Net sales in our Engineered Materials segment; • a gain of $515 million in our Engineered Materials segment recognized on the formation of the Nutrinova joint venture (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information); and • lower raw material and sourcing costs in our Acetyl Chain segment, primarily for ethylene, methanol and acid; partially offset by: • higher raw material costs and spending in our Engineered Materials segment as a result of additional production capacity gained through the M&M Acquisition; and • lower Net sales in our Acetyl Chain segment.
Operating profit decreased $2.4 billion, or 141%, for the year ended December 31, 2024 compared to the same period in 2023 primarily due to: • an unfavorable impact of $1.7 billion to Other (charges) gains, net primarily in our Engineered Materials segment related to an impairment loss on goodwill of $1.5 billion and impairment losses on certain trade names, primarily Zytel ® (see Note 9 - Goodwill and Intangible Assets, Net and Note 24 - Other (Charges) Gains, Net in the accompanying consolidated financial statements for further information); • lower Net sales across our segments; and • a gain of $515 million in our Engineered Materials segment recognized on the formation of the Nutrinova joint venture during the year ended December 31, 2023, which did not recur in the current year (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information); partially offset by: • lower raw material costs in our Engineered Materials and Acetyl Chain segments.
In Engineered Materials, at our Nanjing, China facility, our expansions of (1) the compounding plant and (2) the new liquid crystal polymer ("LCP") plant are on schedule and in construction, and at our Bishop, Texas facility, our debottleneck of the ultra-high molecular weight polyethylene ("UHMW-PE") unit is on schedule and in detailed engineering design/construction.
In Engineered Materials, at our Nanjing, China facility, our expansions of (1) the compounding plant is in construction and we are accelerating completion to meet demand and (2) the new liquid crystal polymer ("LCP") plant is in construction and remains on schedule under a delayed timeline.
Credit Agreements, the "Global Credit Agreements"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn on January 10, 2023 and was supported by a letter of comfort from us.
Also in January 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates.
On November 1, 2022, we acquired a majority of the M&M Business for a purchase price of $11.0 billion, subject to transaction adjustments, in an all-cash transaction.
For further information regarding the food ingredients joint venture, see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements. 42 Table of Contents In November 2022, we acquired a majority of the M&M Business for a purchase price of $11.0 billion, subject to transaction adjustments, in an all-cash transaction.
Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations. We are in compliance with all of the covenants related to our debt agreements as of December 31, 2023.
Covenants Our material financing arrangements contain customary covenants, including the maintenance of certain financial ratios, events of default and change of control provisions. Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations.
Operating profit decreased for the year ended December 31, 2023 compared to the same period in 2022 primarily due to: • lower Net sales; partially offset by: • lower raw material and sourcing costs, primarily for ethylene, methanol and acid. 40 Table of Contents Other Activities Year Ended December 31, % 2023 2022 Change Change (In $ millions, except percentages) Operating profit (loss) (505) (498) (7) (1.4) % Non-operating pension and other postretirement employee benefit (expense) income (68) 17 (85) (500.0) % Year Ended December 31, 2023 Compared to Year Ended December 31, 2022 Operating loss increased for the year ended December 31, 2023 compared to the same period in 2022 primarily due to: • higher functional spending of $106 million, primarily related to additional sites and employees gained through the M&M Acquisition; partially offset by: • lower merger and acquisition project spending of $66 million; and • a favorable currency impact of $33 million.
Other Activities Year Ended December 31, % 2024 2023 Change Change (In $ millions, except percentages) Operating profit (loss) (469) (505) 36 7.1 % Non-operating pension and other postretirement employee benefit (expense) income (28) (68) 40 58.8 % Year Ended December 31, 2024 Compared to Year Ended December 31, 2023 Operating loss decreased for the year ended December 31, 2024 compared to the same period in 2023 primarily due to: • lower functional spending and incentive compensation cost of $33 million.
Business Segments Engineered Materials Year Ended December 31, % 2023 2022 Change Change (In $ millions, except percentages) Net sales 6,149 4,024 2,125 52.8 % Net Sales Variance Volume 54 % Price (1) % Currency — % Operating profit (loss) 1,083 429 654 152.4 % Operating margin 17.6 % 10.7 % Equity in net earnings (loss) of affiliates 83 202 (119) (58.9) % Depreciation and amortization 462 226 236 104.4 % Year Ended December 31, 2023 Compared to Year Ended December 31, 2022 Net sales increased for the year ended December 31, 2023 compared to the same period in 2022 primarily due to: • higher volume, primarily related to the M&M Acquisition and the KEPCO restructuring (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information); partially offset by: • lower pricing for most of our products, primarily due to decreased energy surcharges, market considerations, and an unfavorable product mix, particularly in Asia and Europe.
Business Segments Engineered Materials Year Ended December 31, % 2024 2023 Change Change (In $ millions, except percentages) Net sales 5,607 6,149 (542) (8.8) % Net Sales Variance Volume (5) % Price (3) % Currency (1) % Other (charges) gains, net (1,724) (56) (1,668) (2,978.6) % Operating profit (loss) (1,179) 1,083 (2,262) (208.9) % Operating margin (21.0) % 17.6 % Equity in net earnings (loss) of affiliates 172 83 89 107.2 % Depreciation and amortization 510 462 48 10.4 % Year Ended December 31, 2024 Compared to Year Ended December 31, 2023 Net sales decreased for the year ended December 31, 2024 compared to the same period in 2023 primarily due to: • lower volume, primarily driven by the formation of the Nutrinova joint venture (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information) and reduced demand for elastomers due to weaker automotive demand, partially offset by higher volume for certain products, principally for POM in Europe and Asia; • lower pricing for most of our products, primarily due to competitive market dynamics, product mix, and decreased energy surcharges; and • an unfavorable currency impact, primarily resulting from a weaker JPY and CNY relative to the U.S. dollar. 40 Table of Contents Operating profit decreased for the year ended December 31, 2024 compared to the same period in 2023 primarily due to: • an unfavorable impact of $1.7 billion to Other (charges) gains, net primarily related to an impairment loss on goodwill of $1.5 billion and impairment losses on certain trade names, primarily Zytel ® (see Note 9 - Goodwill and Intangible Assets, Net and Note 24 - Other (Charges) Gains, Net in the accompanying consolidated financial statements for further information); • a gain of $515 million recognized on the formation of the Nutrinova joint venture during the year ended December 31, 2023, which did not recur in the current year (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information); and • lower Net sales; partially offset by: • lower raw materials costs for most of our products.
In furtherance of these deleveraging efforts, we have paused our share repurchase program and are in the process of evaluating additional cash generation opportunities which may also include, in addition to the food ingredients joint venture described above, additional opportunistic dispositions or monetization of other product or business lines or other assets.
We will continue to evaluate our dividend policy, taking into account our ability to return to a balanced capital allocation strategy. Our deleveraging efforts may also include, in addition to the food ingredients joint venture described above, other opportunistic dispositions or monetization of other product or business lines or other assets.
We continue to prioritize projects that drive growth and productivity in the near term and expect total capital expenditures to be approximately $400 million in 2024, primarily due to certain investments in growth opportunities and productivity improvements.
We continue to focus our near-term capital expenditures on required maintenance projects and productivity improvements, as we continue to prioritize deleveraging and expect total capital expenditures to be approximately $300 million to $350 million in 2025.
Term Loan Facility was fully drawn during the three months ended December 31, 2022. The 364-day Term Loans and 3-year Term Loans have been fully repaid. Also in March 2022, we entered into a new revolving credit agreement (the "U.S. Revolving Credit Agreement" and, together with the U.S. Term Loan Credit Agreements the "U.S.
Term Loan Credit Agreement was not drawn during the year ended December 31, 2024. 45 Table of Contents On December 10, 2024, CNC entered into a credit facility agreement (the "CNC Revolving Credit Agreement," together with the CNC Three Year Working Capital Loan Agreement, the CSIT Revolving Credit Agreement, the China Working Capital Term Loan Agreement and the CNC Working Capital Loan Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S.
Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027. The proceeds of a $365 million borrowing under the new senior unsecured revolving credit facility were used to repay and terminate our then-existing revolving credit facility.
Also in March 2022, we entered into a new revolving credit agreement (as amended to date, the "U.S. Revolving Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027.
On February 21, 2023 and February 16, 2024, we amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants. On August 9, 2023, we amended certain covenants in the March 2022 U.S. Term Loan Credit Agreement to permit refinancing certain senior notes without requiring a mandatory prepayment under the March 2022 U.S. Term Loan Credit Agreement.
We are in compliance with all of the covenants related to our debt agreements as of December 31, 2024. On February 17, 2025, November 1, 2024, February 16, 2024, August 9, 2023 and February 21, 2023, we amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants.
The other major projects that support the Acetyl Chain are in various stages of construction or commissioning and on schedule. These projects include our planned expansions of (1) our vinyl acetate ethylene ("VAE") emulsions units in Nanjing, China, and (2) our VAE emulsion plant in Frankfurt, Germany.
In the Acetyl Chain, our planned expansion of our vinyl acetate ethylene ("VAE") emulsion plant in Frankfurt, Germany is in construction and on schedule for start-up in the second half of 2025.
The March 2022 U.S. Term Loan Credit Agreement and the U.S. Revolving Credit Agreement are, and the September 2022 U.S. Term Loan Credit Agreement was, guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations (the "Subsidiary Guarantors").
On February 21, 2023, August 9, 2023, February 16, 2024, November 1, 2024 and February 17, 2025, we amended certain covenants in certain of the U.S. Credit Agreements, including financial ratio maintenance covenants. The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of our U.S. assets and business operations (the "Subsidiary Guarantors").
We expect to incur additional exit and shutdown costs related to the closure of the PA66 and HPN polymerization units in Uentrop, Germany of approximately $70 million in 2024, inclusive of estimated employee termination costs. On September 27, 2023, we formed a food ingredients joint venture with Mitsui & Co., Ltd. ("Mitsui") under the name Nutrinova.
We fully ceased operation of the PA66 polymerization unit and partially ceased operation of the HPN polymerization units during the year ended December 31, 2024. See Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements. In September 2023, we formed a food ingredients joint venture with Mitsui & Co., Ltd. ("Mitsui") under the name Nutrinova.
Our energy optimization productivity project at our polyoxymethylene ("POM") unit in Frankfurt, Germany is in detailed engineering design. In the Acetyl Chain, our planned expansion of our acetic acid unit at Clear Lake, Texas is on track to be commissioned and started in the first quarter of 2024.
At our Bishop, Texas facility, our debottleneck of the ultra-high molecular weight polyethylene ("UHMW-PE") unit is on schedule and in detailed engineering design while construction is delayed in line with expected demand growth. Our energy optimization productivity and greenhouse gas reduction project at our polyoxymethylene ("POM") unit in Frankfurt, Germany is on schedule and in detailed engineering design.